PharmaEssentia Corporation (TPE:6446)
502.00
+5.50 (1.11%)
Aug 26, 2025, 10:40 AM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 165.47 billion as of August 25, 2025. Its market cap has decreased by -23.91% in one year.
Market Cap
165.47B
Enterprise Value
145.63B
Revenue
12.63B
Ranking
n/a
PE Ratio
40.97
Stock Price
502.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 165.47B, an increase of 320.13%. That is a compound annual growth rate of 13.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 25, 2025 | 165.47B | -19.18% |
Dec 31, 2024 | 204.73B | 78.68% |
Dec 29, 2023 | 114.58B | -20.34% |
Dec 30, 2022 | 143.84B | 84.26% |
Dec 30, 2021 | 78.07B | 215.94% |
Dec 31, 2020 | 24.71B | 2.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 294.69B |
Bora Pharmaceuticals Co., LTD. | 92.58B |
Lotus Pharmaceutical | 51.02B |
Oneness Biotech | 33.91B |
Polaris Group | 33.28B |
Lumosa Therapeutics | 33.19B |
Center Laboratories | 27.67B |
Pegavision | 24.69B |